Qiagen and DiagnoCure license Organon technology
This article was originally published in Clinica
Executive Summary
DiagnoCure, which specialises in the diagnosis and treatment of urinogenital and breast cancer, is licensing two technologies from Organon Teknika, part of Akzo Nobel.